CORCEPT THERAPEUTICS INC
CORT
84 insider filings · Latest: Oct 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2024 | Sep 3 3:33 PM | Guyer William | Proposed Sale | 10,000 | $35.30 | $353.0K | — | View → |
| Aug 26, 2024 | Aug 26 7:37 PM | Robb Gary Charles | Proposed Sale | 3,101 | $35.71 | $110.7K | — | View → |
← Previous
Page 8 of 8
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Mar 3 11:16 PM | Atabak MokariChief Financial Officer | Grant/Award | 140,000 | $35.70 | 140,000(D) | View → |
| Feb 27, 2026 | Mar 3 11:14 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Grant/Award | 140,000 | $35.70 | 140,000(D) | View → |
| Feb 27, 2026 | Mar 3 11:14 PM | Hazel HuntChief Scientific Officer | Grant/Award | 140,000 | $35.70 | 140,000(D) | View → |
| Feb 27, 2026 | Mar 3 11:13 PM | Gary Charles RobbChief Business Officer | Grant/Award | 140,000 | $35.70 | 140,000(D) | View → |
| Feb 27, 2026 | Mar 3 11:13 PM | William GuyerChief Development Officer | Grant/Award | 140,000 | $35.70 | 140,000(D) | View → |
| Feb 24, 2026 | Feb 26 9:45 PM | James N WilsonDirector | Option Exercise | 100,000 | $3.88 | 0(D) | View → |
| Feb 9, 2026 | Feb 11 10:26 PM | Hazel HuntChief Scientific Officer | Option Exercise | 150,000 | $3.88 | 0(D) | View → |
| Feb 3, 2026 | Feb 5 10:42 PM | William GuyerChief Development Officer | Option Exercise | 20,000 | $21.65 | 230,000(D) | View → |
| Jan 27, 2026 | Jan 29 9:10 PM | BAKER G LEONARD JRDirector | Option Exercise | 140,000 | $15.15 | 0(D) | View → |
← Previous
Page 3 of 3